Endnotes

Public Health Supply Chain a​nd Industrial Base 
One-Year Report​

1. Executive Order No. 14017 of February 24, 2021, America’s Supply Chains, 86 Fed. Reg. 11849, Section 4(ii).
2. Department of Defense, Departmen​t of Health and Human Services, Department of Homeland Security, Department of Veterans Affairs, National Strategy for a Resilient Public Health Supply Chain, July 2021, 17.
3. “COVID-19 Vaccinations in the United States,” COVID Data Tracker, Centers for Disease Control (CDC), accessed January 5, 2022.
4. “U.S. International COVID-19 Vaccine Donations Tracker,” Kaiser Family Foundation, accessed January 5, 2022.
5. ​​ National Strategy for a Resilient Public Health Supply Chain, July 2021, 70.
6. Ibid., 60-64.
7. The White House, Building Resilient Supply Chains, Revitalizing American Manufacturing, and Fostering Broad-Based Growth, June 2021, 208.
8. National Strategy for a Resilient Public Health Supply Chain, 60-64.
9. “Personal Protective Equipment,” the National Institute for Occupational Safety and Health, CDC, accessed January 3, 2022.
10. “ASPR Program Office for Innovation and Industrial Base Expansion (IBx),” ASPR, accessed January 3, 2022.
11. “H.R. 3864 - Infrastructure Investment and Jobs Act,” U.S. Congress, House of Representatives, November 15, 2021, Sec. C.
12. National Strategy for a Resilient Public Health Chain, 71-72.
13. U.S. Congress, Senate Committee on Health, Education, Labor, and Pensions, Addressing New Variants: A Federal Perspective on the COVID-19 Response: Hearing before the U.S. Senate Committee on Health, Education, Labor & Pensions, Testimony of Janet Woodcock, 117th Cong., 2nd sess., January 11, 2022, 4, 9, 12, 17.
14. “BARDA-NIOSH Mask Innovation Challenge Selects 10 Winning Concepts for $10,000 Phase 1 Prizes,” Biomedical Advanced Research and Development Authority (BARDA), July 2, 2021.
15. “Mask Innovation Challenge: Phase 2,” BARDA, accessed January 5, 2022.
16. “In Vitro Diagnostics EUAs,” Food and Drug Administration, updated November 15, 2021.
17. “COVID-19 Testing Supply Chain,” Sarata, Amanda K. and Simi V. Siddalingaiah, Congressional Research Service, February 25, 2021.
18. The White House, “President Biden Announces New Actions to Protect Americans Against the Delta and Omicron Variants as We Battle COVID-⁠19 this Winter,” December 2, 2021.
19. “Rapid Acceleration of Diagnostics (RADx),” National Institutes of Health, accessed May 13, 2021.
20. National Strategy for a Resilient Public Health Supply Chain, 50.
21. Building Resilient Supply Chains, Revitalizing American Manufacturing, and Fostering Broad-Based Growth, 208.
22. “Testimony of Janet Woodcock,” January 11, 2022, 2-3.
23. “Security of America’s Medical Product Supply Chain,” The National Academies of Sciences, Engineering and Medicine (NASEM), accessed January 5, 2022.
24. Security of America’s Medical Product Supply Chain - Committee Meeting 2 and Public Workshop,NASEM, December 1-3, 2020.
25. “BioMaP Consortia RFI Final Document,” BARDA, October 21, 2021.
26. “COVID-19 Therapeutics,” ASPR, accessed January 28, 2022.
27. “Testimony of Janet Woodcock,” January 11, 2022, 15.
28. “H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022,” U.S. Congress, House of Representatives, December 2, 2021, Sec. 109.​
    ​
    ​
    ​
    ​
    ​
    ​
    ​
    ​
    ​
    ​